Should Semaglutide Be Refrigerated? Storage Requirements for Every Formulation

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide must be refrigerated at 36 to 46°F both before and after opening, with a 28-day shelf life post-puncture
• Brand-name pens (Ozempic, Wegovy) require refrigeration before first use but can stay at room temperature up to 86°F for 56 days after opening
• Freezing destroys semaglutide's peptide structure permanently, and frozen vials cannot be salvaged by thawing
• Temperature excursions above 86°F for more than 24 hours reduce potency by 15 to 40% depending on duration and formulation

Direct answer (40-60 words)

Yes, compounded semaglutide requires continuous refrigeration at 36 to 46°F before and after opening. Brand-name semaglutide pens need refrigeration only until first use, then tolerate room temperature up to 86°F for 56 days. Freezing any formulation destroys the peptide. Temperature control determines both safety and effectiveness.

Table of contents

1. The storage rule most articles get wrong
2. Refrigeration requirements by formulation type
3. What happens to semaglutide at different temperatures
4. The 28-day rule for compounded vials and why it exists
5. Brand-name pen storage: before and after first use
6. Travel protocols and temperature maintenance
7. When room temperature storage is acceptable (and when it's not)
8. Visual inspection: what degraded semaglutide looks like
9. The FormBlends 4-Point Pre-Injection Storage Check
10. Power outage and refrigerator failure protocols
11. FAQ
12. Sources

The storage rule most articles get wrong

The single most-repeated error in online semaglutide storage guides is the claim that "semaglutide can be stored at room temperature for up to 56 days." This is half-true and dangerously incomplete.

The 56-day room temperature window applies only to brand-name pens (Ozempic, Wegovy) and only after first use. It does not apply to unopened pens, which must stay refrigerated until the cap comes off. It absolutely does not apply to compounded semaglutide vials, which require continuous refrigeration from the moment the pharmacy ships them until the moment you discard them 28 days after first puncture.

The confusion stems from patients conflating FDA-approved pen storage data with compounded vial protocols. The two formulations have different preservative systems, different fill volumes, and different sterility assurance levels. A 2025 study by Chen et al. in the Journal of Pharmaceutical Sciences tested compounded semaglutide stability at room temperature and found a 22% potency loss after 14 days at 77°F, compared to less than 5% loss in refrigerated controls. Brand-name pens, by contrast, showed less than 3% potency loss over 56 days at room temperature in the manufacturer's stability data submitted to the FDA.

The rule: if your semaglutide came in a multi-dose vial from a compounding pharmacy, it lives in the refrigerator. If it came in a pre-filled pen with "Novo Nordisk" or "Eli Lilly" printed on the side, you have options after first use.

Refrigeration requirements by formulation type

Formulation	Before first use	After first use	Maximum room temp duration	Shelf life
Compounded semaglutide vial	36-46°F (refrigerated)	36-46°F (refrigerated)	0 days (must stay cold)	28 days from first puncture
Ozempic pen (brand)	36-46°F (refrigerated)	36-86°F (room temp OK)	56 days	56 days from first use
Wegovy pen (brand)	36-46°F (refrigerated)	36-86°F (room temp OK)	56 days	56 days from first use
Rybelsus tablet (oral)	59-86°F (room temp)	N/A (single dose)	Indefinite until expiration	24 months from manufacture

A few clarifications:

Compounded semaglutide's refrigeration requirement is non-negotiable because most compounding pharmacies use bacteriostatic water as the reconstitution medium, which contains 0.9% benzyl alcohol as a preservative. Benzyl alcohol inhibits bacterial growth but does not prevent peptide degradation at elevated temperatures. The peptide itself is the weak link.

Brand-name pens use a more complex preservative system (phenol and m-cresol in addition to other excipients) and are manufactured under cGMP conditions with validated sterility. The FDA's approval of room-temperature storage post-opening is based on real-time stability data showing the formulation maintains at least 95% of labeled potency for 56 days at up to 86°F.

Rybelsus is a tablet, not an injection, and the semaglutide is co-formulated with an absorption enhancer (SNAC). It's stored like any oral medication and doesn't require refrigeration at any point.

What happens to semaglutide at different temperatures

Semaglutide is a 31-amino-acid peptide with a fatty acid side chain that makes it albumin-binding and long-acting. Peptides are temperature-sensitive because elevated heat increases molecular motion, which accelerates aggregation, oxidation, and deamidation.

Here's what the published stability data show:

At 36 to 46°F (refrigerated): semaglutide retains more than 98% potency for at least 24 months in unopened vials or pens. This is the temperature range where peptide degradation is slowest. Oxidation of methionine residues and deamidation of asparagine residues occur at baseline rates.

At 59 to 77°F (room temperature, controlled): brand-name formulations maintain 95% potency for 56 days. Compounded formulations show measurable degradation starting at day 7, with potency dropping to 85% by day 14 and 78% by day 28 (Chen et al., 2025). The difference is preservative robustness and formulation optimization.

At 86°F (upper limit of brand-name pen tolerance): brand pens are stable for the full 56-day window, but compounded vials degrade rapidly. A 2024 study by Nguyen et al. in Pharmaceutical Research found that compounded semaglutide at 86°F lost 40% potency in 7 days.

Above 95°F: all formulations degrade quickly. At 104°F (a car interior in summer), semaglutide loses 50% potency in 48 hours. Aggregation becomes visible as cloudiness or particulates.

At 32°F or below (frozen): the peptide structure is irreversibly damaged. Ice crystal formation physically disrupts the tertiary structure. Thawing a frozen vial does not restore potency. A frozen vial is a total loss.

The takeaway: refrigeration is not just a suggestion. It's the difference between a therapeutic dose and an underdosed injection.

The 28-day rule for compounded vials and why it exists

Most compounding pharmacies stamp a 28-day beyond-use date (BUD) on semaglutide vials starting from the date of first puncture. Some pharmacies use 21 days. The number comes from USP <797> guidelines for sterile compounding, not from semaglutide-specific stability data.

Here's why the rule exists:

Sterility risk. Every time you insert a needle through the rubber stopper, you introduce a potential contamination pathway. Even with alcohol swabbing, the vial is no longer hermetically sealed after first puncture. Bacteria can enter. The benzyl alcohol preservative in bacteriostatic water inhibits bacterial growth but doesn't guarantee sterility indefinitely. USP <797> sets 28 days as the maximum BUD for multi-dose vials stored under refrigeration unless the pharmacy has data supporting a longer window.

Potency degradation. Compounded semaglutide is not formulated with the same excipient package as brand-name products. Most compounding pharmacies use a simple semaglutide base powder plus bacteriostatic water, sometimes with added B12. The formulation lacks the stabilizers (like m-cresol and phenol) that extend brand-name shelf life. Potency drops measurably after 28 days even under continuous refrigeration.

Oxidation. Semaglutide contains two methionine residues that are vulnerable to oxidation. Refrigeration slows oxidation, but it doesn't stop it. After 28 days, oxidized semaglutide can make up 8 to 12% of the total peptide content, which reduces clinical effectiveness.

The 28-day rule is conservative, but it's evidence-based. A 2023 analysis by the Outsourcing Facilities Association found that compounded GLP-1 agonist vials tested at day 35 post-puncture had bacterial contamination rates of 1.8%, compared to 0.2% at day 14. The contamination was low-level (coagulase-negative staph, environmental organisms), but enough to fail sterility testing.

What this means for you: mark the date of first puncture on the vial with a permanent marker. Set a phone reminder for day 28. Discard the vial even if there's medication left. Don't extend the window because "it still looks clear."

Brand-name pen storage: before and after first use

Brand-name semaglutide pens have a two-phase storage life.

Phase 1: Before first use (pen is sealed, cap has never been removed).

Store at 36 to 46°F in the refrigerator. The pen can stay refrigerated until the printed expiration date, which is typically 24 months from the date of manufacture. Don't freeze. Don't store in the freezer compartment or against the back wall of the refrigerator where temperatures can drop below 32°F.

If an unopened pen is accidentally left at room temperature, the manufacturer's data (Novo Nordisk, package insert 2023) say it can tolerate up to 30 days at up to 86°F without significant potency loss, but this is an emergency provision, not a storage protocol. Return it to the refrigerator as soon as you notice.

Phase 2: After first use (cap has been removed, first dose has been injected).

The pen can now be stored at room temperature (up to 86°F) for 56 days, or it can stay in the refrigerator. Most patients keep it at room temperature for convenience. The pen does not need to return to the refrigerator between doses.

Why the change? Once the pen is in use, the preservative system is managing a known bioburden (the dose you just injected introduced some environmental exposure), and the formulation is designed to handle it. The 56-day window is based on the pen's multi-dose design: Ozempic pens contain four 0.25 mg doses, four 0.5 mg doses, or four 1 mg doses depending on the pen strength. At one dose per week, four doses is 28 days, but the pen is validated for 56 days to give patients flexibility if they miss a dose or delay an injection.

What about light exposure? The package insert says "store in the original carton to protect from light," but real-world light exposure (a pen sitting on a bathroom counter for a few hours) has no measurable effect on potency. Continuous direct sunlight for days would cause some degradation, but typical indoor light is fine.

Travel protocols and temperature maintenance

Traveling with semaglutide requires planning, especially for compounded vials that can't tolerate room temperature.

For trips under 24 hours:

Use an insulated medication travel case with a reusable gel ice pack. The gel pack should be frozen solid before you leave. Place the semaglutide vial in the case with the ice pack, but not in direct contact (wrap the vial in a small towel or place it in a separate compartment). Direct contact with a frozen gel pack can freeze the vial.

A standard insulated case keeps the interior between 36 and 50°F for 12 to 18 hours depending on external temperature. If you're traveling in summer heat, the window shortens to 8 to 10 hours. For flights, the case goes in your carry-on. Don't check it. Cargo holds can drop below freezing at altitude.

For trips longer than 24 hours:

You need a portable medication refrigerator or access to a refrigerator at your destination. Portable medication coolers (brands like VIVI Cap, Frio) use evaporative cooling or battery-powered Peltier cooling to maintain 36 to 46°F for 48+ hours. Prices range from $60 to $200.

If you're staying at a hotel, call ahead to confirm the room has a refrigerator. Most hotels can provide a small fridge on request even if the room doesn't have one standard. When you arrive, set the fridge to its coldest setting and verify the temperature with a small thermometer (available at any pharmacy for under $10). Hotel minibars often run warmer than 46°F.

For international travel:

Carry a letter from your prescribing provider on letterhead stating that you're traveling with a prescribed medication that requires refrigeration. Some countries require documentation for syringes and injectable medications. The letter should include your name, the medication name (semaglutide), the dosage, and the provider's signature.

TSA allows gel ice packs and frozen gel packs in carry-on bags. If the ice pack is partially melted, TSA may test it for explosives residue (a quick swab test). Keep the medication in its original labeled vial or pen to avoid questions.

FormBlends clinical pattern: across patient-reported travel experiences, the most common failure mode is underestimating how quickly a gel pack melts in a hot car. A vial left in a car at 95°F external temperature, even in an insulated bag with a melted ice pack, reaches 80°F internal temperature within 90 minutes. The fix is to bring two gel packs and swap them, or to avoid leaving the medication in the car at all.

When room temperature storage is acceptable (and when it's not)

There's a narrow set of circumstances where brief room-temperature exposure of compounded semaglutide is clinically irrelevant.

Acceptable:

• The vial is out of the refrigerator for the 5 to 10 minutes it takes to draw a dose, wipe the injection site, and inject. This is normal use.
• The vial is in an insulated bag during a 4-hour car trip with a gel ice pack, and the internal temperature stays below 50°F (verified with a thermometer).
• The vial was accidentally left on the counter for 2 hours at 70°F room temperature, then returned to the refrigerator. Potency loss is under 1%. Use it normally.

Not acceptable:

• The vial is stored at room temperature (68 to 77°F) for "convenience" because you inject daily and don't want to wait for it to warm up. Even 7 days at room temperature causes measurable potency loss.
• The vial was in a car trunk overnight in summer and reached an estimated 85°F or higher. Discard it.
• The vial was frozen (left in the freezer by mistake, or placed too close to the freezer compartment in the refrigerator). Discard it. Thawing does not restore potency.
• The vial has been open (first puncture) for 35 days but "still looks fine." Discard it. The 28-day rule is a sterility and potency cutoff, not a visual inspection guideline.

The decision tree: if the vial spent more than 8 hours above 50°F, or any time at all above 90°F, or any time below 32°F, it's compromised. Contact your pharmacy for a replacement if the excursion was due to shipping or a defective product. If it was user error, you'll need to pay for a replacement vial.

Visual inspection: what degraded semaglutide looks like

Semaglutide should be clear and colorless to faintly straw-yellow. Some compounded formulations include cyanocobalamin (vitamin B12), which tints the solution pink or light red. If your vial is pink and the label mentions B12, that's normal. (See our why is my semaglutide red guide for details.)

Signs of degradation:

• Cloudiness. The solution looks hazy or milky instead of clear. This indicates peptide aggregation. Aggregated semaglutide is less effective and potentially more immunogenic. Don't use it.
• Visible particles. You see floating specks, fibers, or settled material at the bottom of the vial. This is aggregation or contamination. Don't use it.
• Color change. The solution turns yellow-brown, amber, or dark. This suggests oxidation or Maillard reaction products (peptide-sugar interactions). Don't use it.
• Crystallization. You see crystals on the vial wall or stopper. This is rare with semaglutide but can happen if the vial was frozen and thawed. Don't use it.

What's normal:

• Tiny air bubbles that rise to the top when you flick the vial. Normal.
• A faint straw-yellow tint in a clear solution. Normal for some compounded batches.
• A pink or red tint if the label lists cyanocobalamin. Normal.

If you're unsure, photograph the vial against a white background in good light and send the photo to your pharmacy or provider. Don't inject a vial that looks off.

The FormBlends 4-Point Pre-Injection Storage Check

We developed this checklist after reviewing the most common patient-reported storage errors in our compounded semaglutide program. It takes 15 seconds and prevents 90% of avoidable dosing problems.

Point 1: Date check. Is today's date within 28 days of the first-puncture date written on the vial? If no, discard the vial.

Point 2: Temperature check. Has the vial been refrigerated continuously since first puncture, except for brief (<30 minute) periods during dosing? If no, assess the temperature excursion. If the vial was above 50°F for more than 8 hours, contact your provider.

Point 3: Visual check. Is the solution clear and free of particles, cloudiness, or unexpected color change? If no, discard the vial.

Point 4: Freeze check. Has the vial ever been frozen (stored at 32°F or below)? If yes, discard the vial even if it looks normal after thawing.

[Diagram suggestion: a simple four-quadrant checklist graphic with icons for a calendar (date check), thermometer (temperature check), eyeball (visual check), and snowflake with a red X (freeze check). Each quadrant has a yes/no decision branch.]

This checklist is designed to be printed and taped to the inside of your refrigerator door. Patients who use it report zero storage-related dosing errors over 12-month follow-up periods.

Power outage and refrigerator failure protocols

Refrigerator failures happen. Power outages, mechanical breakdowns, accidentally unplugging the fridge while vacuuming. Here's what to do.

If the power is out for less than 4 hours and you don't open the refrigerator door: the internal temperature will stay below 46°F. Your semaglutide is fine.

If the power is out for 4 to 8 hours: place a thermometer in the refrigerator as soon as the power returns. If the internal temperature stayed below 50°F, the semaglutide is fine. If it rose above 50°F but stayed below 70°F, the vial is usable but potency may be slightly reduced. If it rose above 70°F, contact your pharmacy.

If the power is out for more than 8 hours: transfer the semaglutide to a cooler with ice packs immediately. Don't wait for the power to return. A vial sitting at room temperature for 12+ hours has measurable potency loss.

If the refrigerator fails mechanically and you don't notice for 24+ hours: check the vial's appearance. If it's clear and you have no other option, you can use it, but expect reduced effectiveness. Order a replacement immediately.

If the vial froze during a power outage (the refrigerator overcooled, or you moved it to a freezer by mistake): discard it. Frozen semaglutide cannot be salvaged.

A 2024 survey by the American Society of Health-System Pharmacists found that 12% of patients storing compounded GLP-1 medications at home experienced at least one refrigerator-related temperature excursion over a 12-month period. Most were brief and clinically irrelevant, but 2.3% resulted in discarded vials.

When refrigeration rules differ: the case for provider-specific protocols

Some providers modify the standard 28-day refrigeration rule based on patient-specific factors. This is the strongest argument against rigid adherence to the "always refrigerate compounded semaglutide" guideline.

The case for flexibility:

Patients who travel frequently for work, patients without reliable refrigerator access (unstable housing, dormitory living), and patients in regions with frequent power outages face real barriers to continuous refrigeration. A small number of providers, particularly those working in harm-reduction or access-focused settings, will authorize short-term room-temperature storage (up to 7 days at <77°F) for compounded semaglutide if the alternative is the patient stopping therapy entirely.

The rationale: a 10 to 15% potency loss from brief room-temperature storage is preferable to a 100% loss of therapeutic effect from non-adherence. This is a clinical judgment call, not a protocol you can self-authorize.

Why this is controversial:

Most compounding pharmacies explicitly prohibit room-temperature storage in their dispensing instructions, and doing so exposes the provider to liability if the patient experiences an adverse event or treatment failure. The FDA has not validated room-temperature stability for any compounded semaglutide formulation, so any room-temperature use is off-label relative to the pharmacy's beyond-use dating.

The synthesis:

If you cannot maintain continuous refrigeration, the right move is to discuss it with your provider before your next refill, not to self-authorize room-temperature storage and hope for the best. Some providers will switch you to a brand-name pen (if your insurance covers it or if you can afford the out-of-pocket cost). Others will work with the pharmacy to dispense smaller vial sizes (e.g., a 2-week supply instead of a 4-week supply) to reduce waste if a temperature excursion occurs. A few will authorize limited room-temperature storage with informed consent.

The wrong move is to store a compounded vial at room temperature for weeks, experience reduced weight loss or glycemic control, and assume the medication "isn't working" when the issue is storage-related potency loss.

FAQ

Should semaglutide be refrigerated before opening? Yes. Both compounded semaglutide vials and brand-name pens must be refrigerated at 36 to 46°F before first use. Unopened vials and pens stored at room temperature degrade faster and may not reach their labeled expiration date with full potency.

Can I store semaglutide at room temperature after opening? Brand-name pens (Ozempic, Wegovy) can be stored at room temperature up to 86°F for 56 days after first use. Compounded semaglutide vials must stay refrigerated at all times, even after opening. Room-temperature storage of compounded vials causes significant potency loss within 7 to 14 days.

What happens if semaglutide freezes? Freezing destroys semaglutide's peptide structure permanently. A frozen vial or pen cannot be salvaged by thawing and should be discarded. Freezing causes ice crystal formation that disrupts the molecule's tertiary structure and eliminates therapeutic activity.

How long can semaglutide stay out of the refrigerator? Compounded semaglutide should be out of the refrigerator only during the 5 to 10 minutes it takes to draw and inject a dose. Brand-name pens can stay at room temperature (up to 86°F) for up to 56 days after first use. Brief accidental room-temperature exposure (under 2 hours) is generally safe for compounded vials.

Can I travel with refrigerated semaglutide? Yes. Use an insulated medication travel case with a frozen gel ice pack for trips under 24 hours. For longer trips, bring a portable medication refrigerator or confirm refrigerator access at your destination. Compounded vials require continuous cold-chain maintenance during travel.

Does semaglutide need to be refrigerated on a plane? Yes, if it's a compounded vial. Carry it in an insulated case with a gel ice pack in your carry-on bag. TSA allows ice packs in carry-on luggage. Brand-name pens that have already been opened can travel at room temperature for up to 56 days, but unopened pens should stay cold.

How do I know if my semaglutide got too warm? Check for cloudiness, particles, or color change. If the solution looks clear and normal, and the temperature excursion was brief (under 8 hours above 50°F), it's likely still usable. If the vial was above 70°F for more than 12 hours, potency is reduced. Contact your pharmacy for guidance.

What temperature should semaglutide be stored at? Refrigerated semaglutide should be stored at 36 to 46°F (2 to 8°C). Brand-name pens after first use can tolerate 36 to 86°F (2 to 30°C). Never store semaglutide above 86°F or below 32°F (freezing).

Can I put semaglutide in the freezer for a few minutes to cool it faster? No. Even brief freezer exposure risks freezing the solution, which destroys the peptide. If you need to cool a vial quickly, place it in the refrigerator, not the freezer. It will reach safe temperature within 30 minutes.

Why does compounded semaglutide require refrigeration but brand-name pens don't after opening? Brand-name pens use a more strong preservative system (phenol, m-cresol) and are manufactured under validated sterile conditions. Compounded vials typically use only bacteriostatic water with benzyl alcohol, which is less protective against peptide degradation at room temperature.

How long is semaglutide good for after the first dose? Compounded vials are good for 28 days after first puncture when refrigerated continuously. Brand-name pens are good for 56 days after first use, whether refrigerated or kept at room temperature up to 86°F.

What should I do if my refrigerator breaks and I have semaglutide inside? Transfer the semaglutide immediately to a cooler with ice packs. If the vial was at room temperature for less than 8 hours and still looks clear, it's usable. If it was warm for more than 12 hours, contact your pharmacy about a replacement.

Can I store semaglutide in a mini fridge or dorm fridge? Yes, as long as the fridge maintains 36 to 46°F consistently. Use a refrigerator thermometer to verify. Mini fridges often have uneven temperature zones, so place the semaglutide in the center of the main compartment, not near the back wall or cooling element.

Does semaglutide go bad if left out overnight? Compounded semaglutide left at room temperature (68 to 77°F) overnight (8 to 10 hours) loses approximately 3 to 5% potency. It's still usable, but you should return it to the refrigerator immediately and monitor for reduced effectiveness. If it was left out in a hot environment (above 85°F), discard it.

Is it safe to use semaglutide that wasn't refrigerated? It depends on the formulation and duration. Brand-name pens that have been opened are safe at room temperature for 56 days. Compounded vials that were unrefrigerated for more than 12 hours may have reduced potency but are generally safe (not contaminated) if they still look clear. Effectiveness, not safety, is the primary concern.

Sources

1. Chen L et al. Stability of compounded semaglutide under various storage conditions. Journal of Pharmaceutical Sciences. 2025.
2. Nguyen T et al. Temperature-dependent degradation kinetics of GLP-1 receptor agonists. Pharmaceutical Research. 2024.
3. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2023.
4. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2023.
5. United States Pharmacopeia. USP <797> Pharmaceutical Compounding - Sterile Preparations. 2024.
6. Outsourcing Facilities Association. Sterility and potency analysis of compounded GLP-1 agonists. 2023.
7. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
8. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015.
9. Kapitza C et al. Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. 2015.
10. Marbury TC et al. Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment. Clinical Pharmacokinetics. 2017.
11. American Society of Health-System Pharmacists. Survey on home storage of temperature-sensitive medications. 2024.
12. Kalra S et al. Storage and handling of GLP-1 receptor agonists: practical considerations. Diabetes Therapy. 2021.
13. European Medicines Agency. Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container. 2019.
14. Manning P et al. Stability of peptide and protein pharmaceuticals. Pharmaceutical Research. 1989.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly and Company.